For instance, METTL3 posttranscriptionally upregulates PD-L1 expression in an m6A-IGF2BP3–mediated manner for enhancing stabilization of PD-L1 mRNA in breast carcinoma (30). This evidence concerns the gene METTL3 and breast carcinoma.